CORFLUENT Trademark

Trademark Overview


On Tuesday, March 6, 2018, a trademark application was filed for CORFLUENT with the United States Patent and Trademark Office. The USPTO has given the CORFLUENT trademark a serial number of 87822343. The federal status of this trademark filing is REGISTERED as of Tuesday, June 11, 2019. This trademark is owned by Glaxo Group Limited. The CORFLUENT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardio...
corfluent

General Information


Serial Number87822343
Word MarkCORFLUENT
Filing DateTuesday, March 6, 2018
Status700 - REGISTERED
Status DateTuesday, June 11, 2019
Registration Number5772736
Registration DateTuesday, June 11, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 26, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 13, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Monday, June 18, 2018SUSPENSION LETTER WRITTEN
Friday, March 9, 2018NEW APPLICATION ENTERED
Tuesday, March 13, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 18, 2018ASSIGNED TO EXAMINER
Monday, June 18, 2018LETTER OF SUSPENSION E-MAILED
Monday, June 18, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, June 18, 2018NON-FINAL ACTION WRITTEN
Monday, June 18, 2018NON-FINAL ACTION E-MAILED
Monday, June 18, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 17, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 20, 2018ASSIGNED TO LIE
Thursday, December 20, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 20, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 9, 2019SUSPENSION LETTER WRITTEN
Wednesday, January 9, 2019LETTER OF SUSPENSION E-MAILED
Wednesday, January 9, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, January 24, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, January 31, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 31, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 18, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 26, 2019PUBLISHED FOR OPPOSITION
Tuesday, March 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 11, 2019REGISTERED-PRINCIPAL REGISTER
Friday, October 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 28, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 28, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 23, 2024NOTICE OF SUBMISSION OF E/R PETITION TO REGISTRANT'S EMAIL
Tuesday, July 23, 2024PETITION FOR EXPUNGEMENT RECEIVED 
Tuesday, June 11, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED